SCHEMBL777512

SCHEMBL777512

CC[C@H](O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL777265 1.00
SCHEMBL85852 1.00
SCHEMBL27289630 0.96
SCHEMBL27982449 0.96
Acetaldehyde SCHEMBL27469039 0.85 TSHR (0.40)
SCHEMBL14937631 0.83 TSHR (0.45)
SCHEMBL106122 0.79
SCHEMBL3747066 0.79
SCHEMBL10076291 0.79
SCHEMBL2985874 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102603526-B Synthetic method of 3,13-dimethyl pentadecylic acid (S)-2'-methyl-3'-tetranitrate UNIV NANJING FORESTRY 2013-12-04 CN claimed
CN-102603526-A Synthetic method of 3,13-dimethyl pentadecylic acid (S)-2'-methyl-3'-tetranitrate UNIV NANJING FORESTRY 2012-07-25 CN claimed
WO-2025217091-A1 ODORANTS FOR FLUIDS, ODORIZED FLUIDS, METHODS, AND SYSTEMS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-10-16 WO disclosed
WO-2025217099-A1 INHIBITORS FOR HYDROGEN EMBRITTLEMENT AND METHODS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-10-16 WO disclosed
US-11834447-B2 Indole derivatives and use thereof PURDUE PHARMA L.P. (US) 2023-12-05 US disclosed
US-20230357254-A1 IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17 JANSSEN PHARMACEUTICA NV (BE) 2023-11-09 US disclosed
US-11702422-B2 Imidazopyridazines as modulators of IL-17 JANSSEN PHARMACEUTICA NV (BE) 2023-07-18 US disclosed
US-11691979-B2 Imidazopyridazines as modulators of IL-17 JANSSEN PHARMACEUTICA NV (BE) 2023-07-04 US disclosed
US-20180208575-A1 TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF PURDUE PHARMA L.P. 2018-07-26 US disclosed
US-10005768-B2 Carboxamide derivatives and use thereof PURDUE PHARMA L.P. (US) 2018-06-26 US disclosed
US-20180036294-A1 9H-PYRIMIDO [4,5-B] INDOLES AS BET BROMODOMAIN INHIBITORS UNIV MICHIGAN REGENTS (US) 2018-02-08 US disclosed
US-20120071512-A1 5-PYRIDIN-3-YL-1, 3-DIHYDRO-INDOL-2-ON DERIVATIVES AND THEIR USE AS MODULATORS OF ALDOSTERONE SYNTHASE AND/OR CYP11B1 NOVARTIS AG (CH) 2012-03-22 US disclosed
US-20120071512-A1 5-PYRIDIN-3-YL-1, 3-DIHYDRO-INDOL-2-ON DERIVATIVES AND THEIR USE AS MODULATORS OF ALDOSTERONE SYNTHASE AND/OR CYP11B1 NOVARTIS AG (CH) 2012-03-22 US disclosed
EP-2351742-A1 INDAZOLE DERIVATIVE Asahi Kasei Pharma Corporation (JP) 2011-08-03 EP disclosed
US-20100210569-A1 Mitochondria-targeting antioxidant therapeutics STELIOU KOSTA 2010-08-19 US disclosed
US-20100204240-A1 Pyridin-2-YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus ARRAY BIOPHARMA INC. (US) 2010-08-12 US disclosed
US-20100137306-A1 HETEROCYCLIC TRPV1 RECEPTOR LIGANDS PURDUE PHARMA L.P. 2010-06-03 US disclosed
US-20100130499-A1 BICYCLOHETEROARYL COMPOUNDS AND THEIR USE AS TRPV1 LIGANDS PURDUE PHARMA L.P. 2010-05-27 US disclosed
US-20100120862-A1 MONOCYCLIC COMPOUNDS AND THEIR USE AS TRPV1 LIGANDS PURDUE PHARMA L.P. 2010-05-13 US disclosed
US-20090170868-A1 TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF PURDUE PHARMA L. P. (US) 2009-07-02 US disclosed